Sleevegastrectomy(SG)wasinitiallydescribed asafirst-step proceduref ollowed byeitherbiliopancreaticdiversionwith duodenalswitcho rRoux-en-Ygastricb ypass in super-superobesep atients.Multiple recentr eportshaved ocumented SG ass ingle therapyin the treatmentof morbid obesity.However,the indicationsforthisprocedurearestill underevaluation. Accumulating datademonstratethatSG canbeaneffectiveand safe procedureforsuper-super-obeseorhigh-riskpatients eitherasasingle operation orasab ridge tom ore definitivesurgery.SG canalsobep erformed in patients who requireanti-inflammatory medication orin patients withconditionss uchasCrohn'sdisease,c irrhosis,a nemia, ors evere osteoporosisw hichp reclude intestinalbypass.Furthermore, SG represents notonlyasafe alternativef ormorbidlyobese patients on anticoagulantmedication orimmunosuppressive agents but alsoforthosewithmultiple intra-abdominaladhesionsorafterfailed gastricb anding. Inaddition,S Gc anbe performed safelyin morbid obeseadolescents.The main limitation of thisnovel bariatricprocedurei st he lacko fl ongtermdataon sustained weightloss and resolution of obesityrelated comorbidities.Moreover,the factt hatSG isani rreversible operation addst oi ts weakness asab ariatricprocedure,atleast until definitiveresults concerning its efficacyare obtained. SG iseffectiveand safe asasingle-stage procedure forcertain cohortsof patients.However,the broadapplication of SG asasingle-stage procedureinthe bariatricfield canbe established onlyif the procedurei ss tandardized and longtermresults areavailable.
Introduction
Bariatricsurgery isconsidered asthe onlyeffectivetreatmentwith long-termsustained results formorbid obesity [1, 2] .Sleeveg astrectomy(SG)h asbeen introduced asamulti-purposebariatric operation [3] .SG wasinitiallydescribed asafirst-step procedure followed byeitherbiliopancreaticdiversion withd uodenalswitch orRoux-en-Ygastricb ypass in super-super-obesep atients (BMI > 60 kg/m 2 )o rin high-riskp atients [4, 5] . [9] . The stomachi sr educed without functionali mpairment.The pyloricpreservation prevents dumping. Sincen od igestiveanastomosis isinvolved,the whole digestivetractr emainsaccessible toe ndoscopyand the risko fp epticulcerisr educed. Moreover,no foreign materialisused,asin the caseofgastricbanding,nordoesSG alter the absorption of nutrients,vitamins,minerals,and drugs[10].
Indicationsand Limitations
Although classified asarestrictivep rocedure,S Ga ppears tobe morethanjust agastricrestrictiveoperation. Ghrelin,apotentorexigenichormone,ismainlys ynthesized in the gastricfundus [11, 12] .WithSG,a lmost the whole of the gastricfundus iss urgically removed and the levelsof ghrelin aresignificantlyr educed [13] . Thus,S Gisnotonlyamulti-purposeo peration but alsoamultifactorialone,witharestrictiveaspectand acomplexneurohormonalaspectnotyetfullyelucidated [14] . Patients experiencee xcellentw eightloss afterSG alone,a nd multiple recentr eports haved ocumented SG ass ingle therapyin the treatmentof morbid obesity [15, 16] .However,the indicationsfor thisprocedureremain vagueand arestill underevaluation. Laparoscopicsleeveg astrectomy(LSG)canbeo ffered in different groupsof morbidlyobesepatients.
Insuper-super-obesep atients,b ariatricoperationsarem oref requentlyrelated totechnicaldifficultiesduetobadexposureand an undersized operating field,c aused byt he excessivei ntra-abdominalfatdeposition and ponderous fatty livers.SG represents aneffectiveand safe proceduref ort hesep atients eitherasasingle operation orasab ridge tom ored efinitivesurgery afters ignificant improvementof BMI and comorbidities [17] .Moreover,L SG can bebeneficialf orhigh-risko besep atients who requireashort operation duetosevererespiratory,c ardiovasculardisease,oradvanced age [18, 19] .LSG isassociated withm uchl ess surgicali ntervention thanlaparoscopicgastricbypass; itcanbedone withrelativetechnicale aseand short operating time,a nd canthus minimizestress on suchpatients. LSG canalsobep erformed in patients requiring anti-inflammatory medication orin patients withconditionss uchasCrohn'sdisease,c irrhosis,a nemia, ors evereo steoporosis,whichp reclude intestinalbypass.Furthermore,LSG represents asafe alternativefor morbidlyobesewithcontraindicationst om alabsorptiveo perations,including patients on anticoagulantmedication orimmunosuppressiveagents asw ell asadolescents [20] .Inaddition,L SG hasbeen reported tobeasafe and effectiveo ption forpatients withm ultiple intra-abdominaladhesions,a fterextensivep revious surgery,and forpatients in need of rapid weightloss asafirst step toanon-bariatricsecond procedure [7, 21] .Otherindicationsfor LSG asaprimary procedureinclude morbidlyobesepatients in endemicregions(e.g.Japan,C hile) atr isko fstomachcancer,where ongoing endoscopicsurveillancei sr equired [7] .SG hasalsobeen used effectivelyasaredo procedurei np atients afterfailed gastric banding [22, 23] .Finally,recentr eports demonstrated the shorttermefficacyof SG in the managementof morbidlyobesepatients withtype 2diabetesmellitus and the metabolicsyndrome [24] . 'Durable' weightloss isone of the most importantbenefits of bariatricsurgery,a nd itisastandardbyw hichsuccess orfailureo f weight-reducing proceduresismeasured. The main limitation of thisnovel bariatricprocedurei st he lacko fl ong-term( >5 years) dataon sustained weightloss and resolution of obesity-related comorbidities.Therei sno clearevidencesof art hatw eightloss obtained withLSG canbem aintained in the long term. Onthe contrary,earlyr esults in small cohorts haved emonstrated aregain of bodyweightat5years following LSG ( fig. 2) [9] .Sleevedilation is considered tobeamajorfactorof long-termf ailure. However, therei sno clearevidencethatdilatation occurs afterSG and, furthermore,therei sno datademonstrating thatdilatation ist he main causeoffailureasmorecomplexmechanismsof gastricadaptation plus patients'e ating habits seem top layakeyr ole in the long-termefficacyof SG [25] .Inthe caseofeventualregain of lost weightorinsufficientw eightloss,the surgeon must bereadyt o proceed toasecond operation thatmust bepart of histechnicalarmamentarium. The factthatSG isanirreversible bariatricoperation highlights anothermajorweakness of the procedure,atleast until definitiveresults overits efficacyareo btained. Furthermore,S Ghasbeen reported top osearisko fg astroesophagealreflux,perhapsbecause of alteration in the anatomyof the angle of Hiss [26] .Therefore, SG should beapplied tom orbidlyobesepatients withp re-existing gastroesophagealreflux diseaseinacautious manner. The LSG isnota'simple' procedure. Although low,amortality of approximately1% hasbeen reported,whichinahigh-volume centerforLSG wasincreased to3.2%f ort he groupo fh igh-riskp atients [3, 27] .Additionally,amediancomplication rateof4.5% has recentlybeen demonstrated afteracollectiveanalysisof 17cohorts of patients receiving SG [27] .
Conclusion
LSG isaneffectiveand generallysafe operation asafirst-step procedurebeforeg astricb ypass orduodenalswitchand asasinglestage proceduref orcertain cohorts of patients.Nonetheless,longtermstudiesaren eeded beforeLSG canbeo ffered asasurgical option in the generalbariatricfield. Thus,itmaybeconsidered as stand-alone techniquebut furthers tudiesmust establishadefinitivestandardofthe procedureand alsodemonstratei ts efficacyin the long term.
